SCHEMBL31384228

SCHEMBL31384228

CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1CCCCCCOCCOCCNC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.39
▸ THRB P10828 1/20 0.39
▸ LGALS8 O00214 1/20 0.38
▸ LGALS3 P17931 1/20 0.38
▸ LGALS4 P56470 1/20 0.38
▸ MDK P21741 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ CD69 Q07108 1/20 0.34
▸ B4GALT1 P15291 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ TLR2 O60603 1/20 0.33
▸ TLR1 Q15399 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30980707 0.88 MAPK1 (0.43) MAPK1ALDH1A1THRBLGALS8LGALS3
SCHEMBL30980636 0.86 MAPK1 (0.36) MAPK1ALDH1A1THRBLGALS8LGALS3
SCHEMBL30980704 0.85 MAPK1 (0.52) MAPK1ALDH1A1THRBLGALS8LGALS3
SCHEMBL30980773 0.84 MAPK1 (0.40) MAPK1ALDH1A1THRBLGALS8LGALS3
SCHEMBL30980606 0.83 MAPK1 (0.47) MAPK1ALDH1A1THRBLGALS8LGALS3
SCHEMBL30980757 0.83 MAPK1 (0.46) MAPK1ALDH1A1THRBLGALS8LGALS3
SCHEMBL30980683 0.82 OGA (0.44) MAPK1ALDH1A1THRB
SCHEMBL30980511 0.81 MAPK1 (0.53) MAPK1ALDH1A1THRBLGALS8LGALS3
SCHEMBL31384251 0.81 MAPK1 (0.53) MAPK1ALDH1A1THRBLGALS8LGALS3
SCHEMBL31384238 0.81 MAPK1 (0.53) MAPK1ALDH1A1THRBLGALS8LGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
Send feedback